Having identified the important role of Gal-3 derived from HBsAg+ hepatocytes by using HBs-Tg mice, we speculated that enhanced Gal-3 levels might correlate with HBV-related HCC development. The gene discussed is LGALS3; the disease is hepatocellular carcinoma.